Neuronetics grants RSUs to new employees

From GlobeNewswire: 2024-11-12 16:30:00

Neuronetics, Inc. granted 13,500 Restricted Stock Units (RSUs) to seven new non-executive employees, with each grant vesting ratably on the first, second, and third anniversaries of the grant date. Neuronetics is a medical technology company focused on improving the quality of life for patients with neurohealth disorders. Their NeuroStar® Advanced Therapy system is an FDA-cleared treatment for depression and obsessive-compulsive disorder, with over 6.9 million treatments delivered. The company cautions investors about risks and uncertainties, including the impact of COVID-19 on operations and general economic conditions. For safety information and indications for use, visit NeuroStar.com.



Read more at GlobeNewswire: Neuronetics Reports Inducement Grant Under Nasdaq Listing